Terms: = Liver cancer AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 AND Clinical Outcome
3 results:
1. Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.
Watanabe M; Watanabe N; Maruyama S; Kawashiro T
Drug Metab Pharmacokinet; 2015 Oct; 30(5):325-33. PubMed ID: 26423799
[TBL] [Abstract] [Full Text] [Related]
2. Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine.
Shah RR; Smith RL
Drug Metab Dispos; 2015 Mar; 43(3):400-10. PubMed ID: 25519488
[TBL] [Abstract] [Full Text] [Related]
3. clinical implications of cyp2d6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer.
Lim HS; Ju Lee H; Seok Lee K; Sook Lee E; Jang IJ; Ro J
J Clin Oncol; 2007 Sep; 25(25):3837-45. PubMed ID: 17761971
[TBL] [Abstract] [Full Text] [Related]
